Novartis Venture Fund
Portfolio in Switzerland · Netherlands: 2 funded startups tracked by Uback, 2 of them in a ranking.
Portfolio on Uback2startups, 2 countries
In a ranking2ranked by AI-estimated valuation
On the Radar0eligible, not ranked
Latest deal trackedApr 2025Granite Bio
Portfolio on Uback
Sorted by Uback rank, then Radar by last round| Company | Uback | Sector | Round backed | Valuation (AI) |
|---|---|---|---|---|
| Granite Bio | #20 Switzerland | Biotech › immunology antibodies | Series A + B · USD 100M · Apr 2025 | Hundreds of M$ |
| Alesta Therapeutics | #27 Netherlands | Biotech › rare diseases | Series A · USD 67M · Jan 2025 | Hundreds of M$ |
Only startups that meet Uback’s eligibility rules are shown. Amounts are round sizes, not the fund’s share. Rounds as reported by public sources.
By sector
Deals tracked per year
22025
Co-investors
Versant Ventures · Forbion · Sanofi Ventures · Frazier Life Sciences · Droia Ventures
Investors that joined the same rounds, as reported by public sources.
Last updated: Oct 2026Report a missing dealReport an error
Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction.